06
Feb
Optics play a main role in efficiently delivering the light to the cells for Multiple Sclerosis drug generation
in Interview
Comments
In Optogenerapy project, light fuels the medical device, the energy to activate the engineered cells in the chamber for the production of IFN-ß protein, a therapeutic drug proven effective for the treatment of patients with Multiple Sclerosis. In charge of the implant’s optical design, ASE Optics explains in this interview the importance of optics for channelling the light homogenously to all the cells in the membrane,...
Read More